Simopekka Vänskä

1.2k total citations
35 papers, 523 citations indexed

About

Simopekka Vänskä is a scholar working on Epidemiology, Surgery and Atomic and Molecular Physics, and Optics. According to data from OpenAlex, Simopekka Vänskä has authored 35 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 6 papers in Surgery and 6 papers in Atomic and Molecular Physics, and Optics. Recurrent topics in Simopekka Vänskä's work include Cervical Cancer and HPV Research (18 papers), Hepatitis B Virus Studies (12 papers) and Electromagnetic Scattering and Analysis (6 papers). Simopekka Vänskä is often cited by papers focused on Cervical Cancer and HPV Research (18 papers), Hepatitis B Virus Studies (12 papers) and Electromagnetic Scattering and Analysis (6 papers). Simopekka Vänskä collaborates with scholars based in Finland, Sweden and Spain. Simopekka Vänskä's co-authors include Matti Lehtinen, Joakim Dillner, Samuli Siltanen, Matti Lassas, Matti Taskinen, Iacopo Baussano, Seppo Järvenpää, Jorma Paavonen, Tiina Eriksson and Johannes A. Bogaards and has published in prestigious journals such as PLoS ONE, American Journal of Epidemiology and The Journal of Infectious Diseases.

In The Last Decade

Simopekka Vänskä

30 papers receiving 493 citations

Peers

Simopekka Vänskä
Cosmina Hogea United States
Angelia A. Eick United States
Matthew P. Horning United States
Jung Hee Yoon South Korea
Bruce H. Williams United States
Charlie Quinn United States
Cosmina Hogea United States
Simopekka Vänskä
Citations per year, relative to Simopekka Vänskä Simopekka Vänskä (= 1×) peers Cosmina Hogea

Countries citing papers authored by Simopekka Vänskä

Since Specialization
Citations

This map shows the geographic impact of Simopekka Vänskä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simopekka Vänskä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simopekka Vänskä more than expected).

Fields of papers citing papers by Simopekka Vänskä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simopekka Vänskä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simopekka Vänskä. The network helps show where Simopekka Vänskä may publish in the future.

Co-authorship network of co-authors of Simopekka Vänskä

This figure shows the co-authorship network connecting the top 25 collaborators of Simopekka Vänskä. A scholar is included among the top collaborators of Simopekka Vänskä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simopekka Vänskä. Simopekka Vänskä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leino, Tuija, et al.. (2025). Quantifying the direct and indirect components of COVID-19 vaccine effectiveness during the Delta variant era. Epidemiology and Infection. 153. e59–e59.
2.
Lehtinen, Matti, Laia Bruni, Miriam Elfström, et al.. (2024). Scientific approaches toward improving cervical cancer elimination strategies. International Journal of Cancer. 154(9). 1537–1548. 13 indexed citations
3.
Vänskä, Simopekka, et al.. (2024). Factors associated with parental Human Papillomavirus (HPV) vaccination intention of daughter: A national survey in Finland. Vaccine. 42(3). 701–712. 9 indexed citations
4.
Lehtinen, Matti, Dan Apter, Tiina Eriksson, et al.. (2021). Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland. Cancer Medicine. 10(21). 7759–7771. 3 indexed citations
5.
Pimenoff, Ville N., Tiina Eriksson, Tapio Luostarinen, et al.. (2021). Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial. PLoS Medicine. 18(6). e1003588–e1003588. 12 indexed citations
6.
Elfström, K. Miriam, Antti Mäkitie, Mari Nygård, et al.. (2021). Elimination of HPV–associated oropharyngeal cancers in Nordic countries. Preventive Medicine. 144. 106445–106445. 8 indexed citations
7.
Vänskä, Simopekka, Tapio Luostarinen, Iacopo Baussano, et al.. (2020). Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied. The Journal of Infectious Diseases. 222(6). 948–956. 37 indexed citations
8.
Pimenoff, Ville N., Tiina Eriksson, Heljä‐Marja Surcel, et al.. (2020). Long‐term follow‐up of human papillomavirus type replacement among young pregnant Finnish females before and after a community‐randomised HPV vaccination trial with moderate coverage. International Journal of Cancer. 147(12). 3511–3522. 13 indexed citations
9.
Bogaards, Johannes A., et al.. (2020). The cost-effectiveness profile of sex-neutral HPV immunisation in European tender-based settings: a model-based assessment. The Lancet Public Health. 5(11). e592–e603. 19 indexed citations
10.
Luostarinen, Tapio, Simopekka Vänskä, Tiina Eriksson, et al.. (2019). Occurrence of human papillomavirus (HPV) type replacement by sexual risk‐taking behaviour group: Post‐hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV). International Journal of Cancer. 145(3). 785–796. 22 indexed citations
11.
Lehtinen, Matti, Iacopo Baussano, Jorma Paavonen, Simopekka Vänskä, & Joakim Dillner. (2019). Eradication of human papillomavirus and elimination of HPV-related diseases – scientific basis for global public health policies. Expert Review of Vaccines. 18(2). 153–160. 38 indexed citations
12.
Palmroth, Johanna, Tapio Luostarinen, Dan Apter, et al.. (2018). Evaluation of HPV type‐replacement in unvaccinated and vaccinated adolescent females—Post‐hoc analysis of a community‐randomized clinical trial (II). International Journal of Cancer. 142(12). 2491–2500. 30 indexed citations
13.
Vänskä, Simopekka, Anna Söderlund‐Strand, Ingrid Uhnoo, Matti Lehtinen, & Joakim Dillner. (2018). Estimating effectiveness of HPV vaccination against HPV infection from post-vaccination data in the absence of baseline data. Vaccine. 36(23). 3239–3246. 5 indexed citations
14.
Lehtinen, Matti, Dan Apter, Iacopo Baussano, et al.. (2015). Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial. Vaccine. 33(10). 1284–1290. 39 indexed citations
15.
Vänskä, Simopekka, Kari Auranen, Tuija Leino, et al.. (2013). Impact of Vaccination on 14 High-Risk HPV Type Infections: A Mathematical Modelling Approach. PLoS ONE. 8(8). e72088–e72088. 29 indexed citations
16.
Vänskä, Simopekka, Matti Lassas, & Samuli Siltanen. (2009). Statistical X-ray tomography using empirical Besov priors. 11. 3–32. 11 indexed citations
17.
Taskinen, Matti & Simopekka Vänskä. (2007). Surface integral equations of the picard’s extended maxwell system.
18.
Taskinen, Matti, Simopekka Vänskä, & Pasi Ylä‐Oijala. (2007). Frequency domain surface integral equations of picard's extended Maxwell system. 647–647.
19.
Vänskä, Simopekka, et al.. (2006). Wavelet-based reconstruction for limited-angle X-ray tomography. IEEE Transactions on Medical Imaging. 25(2). 210–217. 115 indexed citations
20.
Vänskä, Simopekka. (2006). Direct and Inverse Scattering for Beltrami Fields. Työväentutkimus Vuosikirja. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026